Content about Neurological disorders

May 7, 2013
Sato Pharmaceutical touts ZenTrip motion sickness solution to New Yorkers on the go

Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.

November 1, 2012
Global MS market to reach $19.5 billion in 2017, report finds

The global market for treatments for neurodegenerative disorders will exceed $20 billion before the end of the decade, according to a new report.

October 15, 2012
NASA, Epiomed Therapeutics partner on development of scopolamine nasal spray

NASA's Johnson Space Center and Epiomed Therapeutics have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

August 28, 2012
Merz acquires Cuvposa

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

July 23, 2012
Pfizer pain drug doesn't affect sperm production, study finds

A drug made by Pfizer for treating pain disorders doesn't affect men's reproductive functions, according to a new post-approval clinical study.

July 5, 2012
FDA approves generic version of Lyrica

The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

June 21, 2012
FDA approves Lyrica for spinal pain

The Food and Drug Administration has approved a new indication for a Pfizer drug.

June 19, 2012
FDA declines to approve Pfizer's tafamidis meglumine

The Food and Drug Administration has declined to approve a drug designed to treat a rare, progressive and fatal neurodegenerative disease.

June 1, 2012
Patients with MS show reduction in symptoms during drug trial

An experimental drug for multiple sclerosis produced a noticeable reduction in symptoms of the disease in a late-stage clinical trial, the drug's developer said Friday.

May 29, 2012
Watson settles with Endo, Teikoku Seiyaku over generic version of Lidoderm patch

Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

May 17, 2012
Prestige Brands highlights new Dramamine for Kids product in fiscal 2012 call

Prestige Brands on Thursday morning announced the launch of Dramamine for Kids.

April 6, 2012
Sam's Club offers screenings for brain health

Sam's Club is offering free screenings for brain health at all of its stores that operate pharmacies this month, the retailer said Friday.

April 4, 2012
FDA approves UCB drug for Parkinson's, restless legs syndrome

The Food and Drug Administration has approved a patch for treating restless legs syndrome and Parkinson's disease.

April 3, 2012
Psi Bands generates 'buzz' at Travel Goods Association trade event

Psi Bands, stylish drug-free wristbands for the relief of nausea, were voted the most buzz-worthy product of the year at the Travel Goods Association trade show held in Las Vegas, the company announced earlier this month. The "Buzz Award" is given once per year to the product that has created the most "buzz" at the Travel Goods Show's New Products Pavilion as voted on by retailers and members of the press.

March 9, 2012
FDA committee to discuss anti-NGF drug class at meeting

A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.

February 15, 2012
FDA accepts Pfizer application for genetic disease drug

The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

February 1, 2012
Impax licenses migraine drug rights from AstraZeneca

Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

January 26, 2012
Pfizer, J&J subsidiary, charity group launch Alzheimer's Challenge 2012

Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer's disease.

January 25, 2012
NARB upholds Advil's challenge of Excedrin's faster-relief claims

The National Advertising Review Board on Tuesday recommended that Novartis Consumer Health discontinue advertising claims that the company’s Excedrin Extra Strength product starts relieving headache pain faster than Advil.

January 17, 2012
Pfizer, Medivation to discontinue Dimebon development following late-stage trial results

A late-stage clinical trial to evaluate a drug in Alzheimer's disease patients came up short, the drug's developers said Tuesday.

January 3, 2012
Study: Children at greater risk of ADHD if mother has gestational diabetes, low socioeconomic status

Mothers that have low socioeconomic status and develop gestational diabetes during pregnancy are more likely to bear children that are diagnosed with attention deficit hyperactivity disorder, according to a new study published in the Archives of Pediatrics & Adolescent Medicine.

December 23, 2011
Bristol-Myers Squibb, Gladstone Institutes to collaborate on Alzheimer's drug discovery

Drug maker Bristol-Myers Squibb and the Gladstone Institutes will collaborate to find new ways to treat Alzheimer's disease, the two said Thursday.

December 15, 2011
FDA to review patch for HIV-related pain

A Food and Drug Administration expert panel will review a drug made by NeurogesX as a potential treatment for pain associated with HIV.

December 7, 2011
Drug shows improvement in symptoms of autism in children

A drug in late-stage clinical trials appears to treat the symptoms of autism, the drug's developer said Wednesday.

November 14, 2011
Genzyme announces phase-3 results of Lemtrada in patients with relapsing MS

A late-stage clinical trial of a drug under development as a treatment for multiple sclerosis has shown "successful" results.

© 2013 Drug Store News. All Rights Reserved.